Skip to main content
Pulike Biological Engineering,Inc. logo

Pulike Biological Engineering,Inc. — Investor Relations & Filings

Ticker · 603566 ISIN · CNE1000025N0 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,080 across all filing types
Latest filing 2020-08-14 Major Shareholding Noti…
Country CN China
Listing Shanghai Stock Exchange 603566

About Pulike Biological Engineering,Inc.

http://en.pulike.com.cn/

Pulike Biological Engineering, Inc. specializes in the research, development, and production of veterinary biological products and pharmaceutical preparations. The company focuses on animal disease prevention through the manufacture of high-end vaccines, diagnostic reagents, and veterinary medicines. Its product range primarily serves the swine and poultry sectors, featuring advanced biologicals such as genetically engineered vaccines and synthetic peptide products. Pulike maintains a strong emphasis on technological innovation, utilizing national-level research platforms to develop solutions for complex animal health challenges. The company’s core activities encompass the entire value chain from basic biotechnology research to the commercialization of veterinary health solutions, aiming to improve livestock productivity and biosecurity.

Recent filings

Filing Released Lang Actions
股东减持股份计划公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement regarding a shareholder's plan to reduce their holdings through centralized bidding transactions. It details the shareholder's current holdings, the planned reduction amount, the method of reduction, and related commitments and risk disclosures. There are no financial statements, earnings data, or management discussions typical of financial reports. The document is a formal notification about a shareholding change by a significant shareholder, which fits the definition of a Major Shareholding Notification (MRQ). The document length is short and focused solely on the shareholding reduction plan, confirming it is not a full report or earnings release.
2020-08-14 Chinese
关于召开2020年第二次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice about convening the 2020 second extraordinary general meeting of shareholders for the company 普莱柯生物工程股份有限公司. It includes information about the meeting date, voting methods, agenda items, shareholder eligibility, and proxy authorization. There is no financial data, earnings information, or report content. The document is a formal announcement of a shareholders meeting, not the meeting materials or results. It fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2020-08-07 Chinese
关于放弃参股公司增资优先认购权暨关联交易的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by 普莱柯生物工程股份有限公司 regarding the waiver of preemptive rights in a capital increase of an associate company, 北京中科基因技术有限公司. It details the transaction overview, related party relationships, financial data of the associate, and the approval process including board and independent directors' opinions. The document is a formal disclosure of a related-party transaction and capital financing update, including governance and approval procedures. It is not a full financial report, earnings release, or audit report, but rather an announcement of a capital/financing update and related transaction. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length and content support this classification with high confidence.
2020-08-07 Chinese
独立董事关于第四届董事会第六次会议的独立意见
Board/Management Information Classification · 95% confidence The document is an independent director's opinion on a specific board meeting agenda item regarding a related party transaction and waiver of preemptive rights in a capital increase. It references the company's board meeting and legal compliance but does not contain financial statements or detailed financial data. The document is short (441 characters) and serves as a formal opinion rather than a full report. This fits best under Board/Management Information (MANG), which covers announcements related to board decisions and management matters.
2020-08-07 Chinese
第四届董事会第六次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of resolutions passed at a board meeting of 普莱柯生物工程股份有限公司 (Pulai Ke Bioengineering Co., Ltd.). It details the convening of the fourth board's sixth meeting, the attendance, and the voting results on specific agenda items, including approval of a proposal related to a related-party transaction and the calling of an extraordinary shareholders' meeting. The document does not contain financial statements or detailed financial data, nor is it a transcript or presentation. It is a formal announcement of board decisions, which fits the category of Board/Management Information (MANG). The document length is short and it is not a report publication announcement or regulatory filing. Therefore, the classification is MANG with high confidence.
2020-08-07 Chinese
关于股份回购进展情况的公告
Transaction in Own Shares Classification · 100% confidence The document is a public announcement from a company regarding the progress of its share repurchase program. It details the number of shares repurchased, prices, total amount spent, and compliance with relevant regulations. The document does not contain financial statements or detailed financial analysis but focuses on the status and details of the share buyback activity. This matches the description of a 'Transaction in Own Shares' filing, which reports on the company's buyback of its own shares. The document length is short and it is not an announcement of a report publication but a substantive update on share repurchase progress.
2020-08-03 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.